Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed yet.

CD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...

While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.

A better understanding of human smell is emerging as scientists interrogate its fundamental elements: the odor molecules that ...

COVID-19 variant N.B.1.8.1, or Nimbus, is more contagious than recent past variants and known to cause a particularly painful ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...